The Alameda, California based BioTime, Inc (NYSEMKT:BTX) announced on Friday that net loss for fiscal Q1 was $7.7 million or $0.15 a share, evaluated against a net loss of $5.0 million or $0.10 a share for same period a year ago.
Total quarterly net revenue tumbled to $431,724 from $631,946 in previous year, because of lower grant revenue linked with the completion of BioTime’s research grant from the California Institute for Regenerative Medicine in August 2012, partially counterbalance by subscription and advertising revenues from LifeMap Science’s online database GeneCards which LifeMap Sciences started marketing in May 2012.
Shifting reader’s focus to broader market, let us consider market performance of other stocks that significantly affect same sector. Hospira, Inc. (NYSE:HSP) rose +0.20% to settle at $34.62, Johnson & Johnson (NYSE:JNJ) moved up +0.72% to end at $85.76 while Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX) jumped +1.93% to finish at $2.64 on Tuesday.
BioTime, Inc. (NYSE:BTX) on May 10, 2013 increased +5.43% to the closing price of $4.08. The overall volume in the last trading session was 107,293 shares. Its fifty two weeks range was $2.67 – $5.07. The total market capitalization remained at $201.48 million.
BTX is ahead of its 52-week low with 52.81% and lagging behind from its 52-week high price with -19.53%. BTX’s last month’s stock price volatility remained 6.40%. In its share capital BTX has 55.73 million outstanding shares, among them 46.12 million shares have been floated in market exchange. BTX’s stock’s institutional ownership remained 32.04% while insider ownership included 14.77%.
The stock price of BTX is moving forward from its 20 days moving average with 8.07% and remote positively from 50 days moving average with 4.72%. BTX’s current year’s earnings per share experienced a downfall of -25.18% while its current quarter performance remained at -5.12%. Company’s beta coefficient included 0.73. Beta factors measure the amount of market risk associated with market trade.
DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! QuoteDaddy.com delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with QuoteDaddy.com! CLICK HERE TO START YOUR FREE 30-DAY TRIAL